Details

Autor(en) / Beteiligte

• Rahman, Md. Mominur
• Bibi, Shabana
• Rahaman, Md. Saidur
• Rahman, Firoza
• Islam, Fahadul
• Khan, Muhammad Saad
• Hasan, Mohammad Mehedi
• Parvez, Anwar
• Hossain, Md. Abid
• Maeesa, Saila Kabir
• Islam, Md. Rezaul
• Najda, Agnieszka
• Al-malky, Hamdan S.
• Mohamed, Hanan R.H.
• AlGwaiz, Hussah I.M.
• Awaji, Aeshah A.
• Germoush, Mousa O.
• Kensara, Osama A.
• Abdel-Daim, Mohamed M.
• Saeed, Mohd
• Kamal, Mohammad Amjad

Titel

Natural therapeutics and nutraceuticals for lung diseases: Traditional significance, phytochemistry, and pharmacology

Ist Teil von

• Biomedicine & pharmacotherapy, 2022-06, Vol.150, p.113041-113041, Article 113041

Ort / Verlag

France: Elsevier Masson SAS

Erscheinungsjahr

2022

Link zum Volltext

Quelle

EZB Electronic Journals Library

Beschreibungen/Notizen

• Lung diseases including chronic obstructive pulmonary disease (COPD), infections like influenza, acute respiratory distress syndrome (ARDS), asthma and pneumonia lung cancer (LC) are common causes of sickness and death worldwide due to their remoteness, cold and harsh climatic conditions, and inaccessible health care facilities. Many drugs have already been proposed for the treatment of lung diseases. Few of them are in clinical trials and have the potential to cure infectious diseases. Plant extracts or herbal products have been extensively used as Traditional Chinese Medicine (TCM) and Indian Ayurveda. Moreover, it has been involved in the inhibition of certain genes/protiens effects to promote regulation of signaling pathways. Natural remedies have been scientifically proven with remarkable bioactivities and are considered a cheap and safe source for lung disease. This comprehensive review highlighted the literature about traditional plants and their metabolites with their applications for the treatment of lung diseases through experimental models in humans. Natural drugs information and mode of mechanism have been studied through the literature retrieved by Google Scholar, ScienceDirect, SciFinder, Scopus and Medline PubMed resources against lung diseases. In vitro, in vivo and computational studies have been explained for natural metabolites derived from plants (like flavonoids, alkaloids, and terpenoids) against different types of lung diseases. Probiotics have also been biologically active therapeutics against cancer, anti-inflammation, antiplatelet, antiviral, and antioxidants associated with lung diseases. The results of the mentioned natural metabolites repurposed for different lung diseases especially for SARS-CoV-2 should be evaluated more by advance computational applications, experimental models in the biological system, also need to be validated by clinical trials so that we may be able to retrieve potential drugs for most challenging lung diseases especially SARS-CoV-2. [Display omitted]